1. Home
  2. TNGX vs BKSY Comparison

TNGX vs BKSY Comparison

Compare TNGX & BKSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • BKSY
  • Stock Information
  • Founded
  • TNGX 2014
  • BKSY 2013
  • Country
  • TNGX United States
  • BKSY United States
  • Employees
  • TNGX N/A
  • BKSY N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • BKSY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • TNGX Health Care
  • BKSY Technology
  • Exchange
  • TNGX Nasdaq
  • BKSY Nasdaq
  • Market Cap
  • TNGX 351.2M
  • BKSY 157.7M
  • IPO Year
  • TNGX N/A
  • BKSY N/A
  • Fundamental
  • Price
  • TNGX $6.01
  • BKSY $22.40
  • Analyst Decision
  • TNGX Strong Buy
  • BKSY Strong Buy
  • Analyst Count
  • TNGX 6
  • BKSY 6
  • Target Price
  • TNGX $12.20
  • BKSY $23.00
  • AVG Volume (30 Days)
  • TNGX 2.7M
  • BKSY 2.3M
  • Earning Date
  • TNGX 08-06-2025
  • BKSY 08-07-2025
  • Dividend Yield
  • TNGX N/A
  • BKSY N/A
  • EPS Growth
  • TNGX N/A
  • BKSY N/A
  • EPS
  • TNGX N/A
  • BKSY N/A
  • Revenue
  • TNGX $40,990,000.00
  • BKSY $107,401,000.00
  • Revenue This Year
  • TNGX N/A
  • BKSY $31.61
  • Revenue Next Year
  • TNGX N/A
  • BKSY $27.90
  • P/E Ratio
  • TNGX N/A
  • BKSY N/A
  • Revenue Growth
  • TNGX 10.09
  • BKSY 7.05
  • 52 Week Low
  • TNGX $1.03
  • BKSY $3.86
  • 52 Week High
  • TNGX $12.02
  • BKSY $24.94
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 76.36
  • BKSY 78.75
  • Support Level
  • TNGX $5.34
  • BKSY $21.10
  • Resistance Level
  • TNGX $6.40
  • BKSY $24.94
  • Average True Range (ATR)
  • TNGX 0.50
  • BKSY 1.84
  • MACD
  • TNGX -0.02
  • BKSY 0.38
  • Stochastic Oscillator
  • TNGX 84.08
  • BKSY 79.81

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

About BKSY BlackSky Technology Inc.

BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.

Share on Social Networks: